Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
F5, INC. | Director | Common Stock | 13,024 | $2.48 M | $190.43 | Mar 13, 2024 | Direct |
Denali Therapeutics Inc. | Director | Common Stock | 21,496 | $438 K | $20.39 | May 31, 2024 | Direct |
F5, INC. | Director | Restricted Stock Unit | 1,309 | $249 K | $190.43 | Mar 14, 2024 | Direct |
Sarcos Technology & Robotics Corp | Director | Common Stock | 265,066 | $157 K | $0.59 | Jun 14, 2023 | Direct |
Accolade, Inc. | Director | Restricted Stock Units | 9,196 | $118 K | $12.86 | Aug 18, 2023 | Direct |
Denali Therapeutics Inc. | Director | Stock Option (right to buy) | 17,901 | May 31, 2024 | Direct |